PRICE T ROWE ASSOCIATES INC /MD/
Position in NBIX — Neurocrine Biosciences Inc
CIK 80255
BALTIMORE, MD
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,250,055
+$36,323,590 QoQ
Shares Held
333,749
+120.7% QoQ
Ownership
0.328%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#54
of 774 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. NBIX ranks #9 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
68,214,436 | $1,083,245,243 | |
| 2 | ALKS |
Alkermes plc.
|
6,737,328 | $353,035,986 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,903,354 | $211,158,092 | |
| 4 | LQDA |
Liquidia Corp
|
1,940,364 | $154,705,221 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
243,444 | $131,905,262 | |
| 6 | PRGO |
PERRIGO Co plc
|
8,700,421 | $90,397,373 | |
| 7 | ZTS |
Zoetis Inc.
|
1,139,097 | $81,855,510 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,679,152 | $56,889,668 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,250,055 | 333,749 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,926,465 | 151,256 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $265,539,799 | 1,872,240 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $402,431,696 | 2,866,731 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $387,936,779 | 3,086,457 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $170,279,870 | 1,539,601 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $203,455,024 | 1,490,513 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $193,013,777 | 1,675,176 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $247,647,403 | 1,798,848 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $251,124,184 | 1,820,796 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $194,602,799 | 1,476,949 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $132,710,624 | 1,179,650 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $125,402,779 | 1,329,828 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $141,115,760 | 1,394,149 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $170,236,637 | 1,425,290 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $155,429,200 | 1,463,414 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $385,658,856 | 3,956,287 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $402,072,187 | 4,288,770 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $371,310,964 | 4,359,645 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $428,169,574 | 4,464,285 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $489,447,485 | 5,029,259 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $561,459,162 | 5,773,359 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $601,145,320 | 6,271,730 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $617,514,326 | 6,421,738 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $814,910,346 | 6,679,593 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $568,700,230 | 6,570,771 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||